CA2836539A1 - Gemcitabine immunoassay - Google Patents

Gemcitabine immunoassay Download PDF

Info

Publication number
CA2836539A1
CA2836539A1 CA 2836539 CA2836539A CA2836539A1 CA 2836539 A1 CA2836539 A1 CA 2836539A1 CA 2836539 CA2836539 CA 2836539 CA 2836539 A CA2836539 A CA 2836539A CA 2836539 A1 CA2836539 A1 CA 2836539A1
Authority
CA
Canada
Prior art keywords
antibody
compound
gemcitabine
group
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2836539
Other languages
English (en)
French (fr)
Inventor
Salvatore J. Salamone
Jodi Blake Courtney
Howard Sard
Christopher SPEDALIERE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saladax Biomedical Inc
Original Assignee
Saladax Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saladax Biomedical Inc filed Critical Saladax Biomedical Inc
Publication of CA2836539A1 publication Critical patent/CA2836539A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/18—Water
    • G01N33/1826—Organic contamination in water
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/18—Water
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/13—Tracers or tags

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
CA 2836539 2011-05-24 2012-05-07 Gemcitabine immunoassay Abandoned CA2836539A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13/114,218 US8426143B2 (en) 2011-05-24 2011-05-24 Gemcitabine immunoassay
US13/114,218 2011-05-24
US13/160,370 US8946392B2 (en) 2011-05-24 2011-06-14 Gemcitabine immunoassay
US13/160,370 2011-06-14
PCT/US2012/036723 WO2012161948A1 (en) 2011-05-24 2012-05-07 Gemcitabine immunoassay

Publications (1)

Publication Number Publication Date
CA2836539A1 true CA2836539A1 (en) 2012-11-29

Family

ID=47217602

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2836539 Abandoned CA2836539A1 (en) 2011-05-24 2012-05-07 Gemcitabine immunoassay

Country Status (7)

Country Link
US (3) US8426143B2 (enExample)
EP (1) EP2715340A4 (enExample)
JP (1) JP2014519036A (enExample)
CN (1) CN103782167B (enExample)
BR (1) BR112013029974A2 (enExample)
CA (1) CA2836539A1 (enExample)
WO (1) WO2012161948A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8426143B2 (en) * 2011-05-24 2013-04-23 Saladax Biomedical Inc. Gemcitabine immunoassay
CA3007357C (en) 2015-12-03 2023-12-05 Epidestiny, Inc. Compositions containing decitabine, 5azacytidine and tetrahydrouridine and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010200A (en) * 1932-11-17 1935-08-06 Internat Carbonic Engineering Sealing device for pressure containers
US3996344A (en) 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US4016146A (en) 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
US4269511A (en) 1979-02-15 1981-05-26 Abbott Laboratories Apparatus and method for measuring the magnitude of polarization of light
US4420568A (en) 1980-07-30 1983-12-13 Abbott Laboratories Fluorescent polarization immunoassay utilizing substituted triazinylaminofluoresceins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5101015A (en) 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
CA2096495C (en) 1992-06-16 2002-07-09 Kathy Palmer Ordonez Dual analyte immunoassay
US7829064B2 (en) 1999-05-10 2010-11-09 Immunomedics, Inc. Anti-CD74 immunoconjugates and methods
FR2836995B1 (fr) * 2002-03-05 2006-09-22 Centre Nat Rech Scient Utilisation de derives de nucleosides comportant un groupement citrate pour la production d'anticorps ayant une affinite pour des nucleosides triphosphorylees et leurs applications
WO2004041203A2 (en) 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US20060177883A1 (en) 2005-02-08 2006-08-10 Saladax Biomedical Inc. 5-Fluoro-uracil immunoassay
CA2602849C (en) 2005-03-30 2013-06-04 Saladax Biomedical Inc. Doxorubicin immunoassay
US8039220B2 (en) 2008-09-17 2011-10-18 Saladax Biomedical Inc. Stabilized standards for busulfan immunoassay
BR112012008772A2 (pt) 2009-10-13 2017-06-20 Rexahn Pharmaceuticals Inc sistemas poliméricos para a liberação de agentes anti-câncer
US8426143B2 (en) * 2011-05-24 2013-04-23 Saladax Biomedical Inc. Gemcitabine immunoassay

Also Published As

Publication number Publication date
EP2715340A4 (en) 2014-12-31
BR112013029974A2 (pt) 2017-01-31
CN103782167A (zh) 2014-05-07
US8946392B2 (en) 2015-02-03
WO2012161948A1 (en) 2012-11-29
US8426143B2 (en) 2013-04-23
US20120301902A1 (en) 2012-11-29
US20120301901A1 (en) 2012-11-29
CN103782167B (zh) 2016-01-20
US20150104818A1 (en) 2015-04-16
EP2715340A1 (en) 2014-04-09
JP2014519036A (ja) 2014-08-07

Similar Documents

Publication Publication Date Title
US9551724B2 (en) 5-fluoro-uracil immunoassay
EP2544540B1 (en) Lenalidomide and thalidomide immunoassays
CA2769998C (en) Imatinib immunoassay
EP2302383A2 (en) Docetaxel conjugates and immunogens for use in an immunoassay
EP1771732B1 (en) Taxol immunoassay
US20140273023A1 (en) Gemcitabine immunoassay
US8946392B2 (en) Gemcitabine immunoassay
AU2012259309A1 (en) Gemcitabine immunoassay
HK1116864B (en) 5-fluoro-uracil immunoassay
HK1147799B (en) 5-fluoro-uracil immunoassay
HK1147800A (en) 5-fluoro-uracil immunoassay
HK1157864A (en) 5-fluoro-uracil immunoassay
HK1175071B (en) Lenalidomide and thalidomide immunoassays

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20180510